Quick Answer
Astrana Health, Inc. reported Net Income Loss of $22.49 million for the year ending 2025.
- Astrana Health, Inc. showed a decrease of -47.9% in Net Income Loss from 2024 to 2025.
- This data is from Astrana Health, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2011 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: -$823.0 thousand | Q2 2013: -$849.1 thousand | Q2 2013: -$1.93 million | Q3 2013: -$1.53 million | Q3 2013: -$980.7 thousand | Q4 2013: -$1.01 million | Q4 2013: -$964.8 thousand | Q1 2014: -$1.16 million | Q1 2014: -$766.4 thousand | Q2 2014: -$1.68 million | Q3 2014: $1.38 million | Q4 2014: -$1.69 million | Q2 2015: -$2.48 million | Q3 2015: -$531.4 thousand | Q4 2015: -$1.69 million | Q2 2016: -$1.32 million | Q3 2016: -$1.36 million | Q4 2016: -$1.73 million | Q1 2017: $4.35 million | Q2 2017: $1.99 million | Q3 2017: $5.62 million | Q1 2018: $2.16 million | Q2 2018: $2.66 million | Q3 2018: $9.11 million | Q1 2019: $140.0 thousand | Q2 2019: $3.55 million | Q3 2019: $3.70 million | Q4 2019: $6.73 million | Q1 2020: $4.05 million | Q2 2020: $7.04 million | Q3 2020: $16.71 million | Q4 2020: $10.06 million | Q1 2021: $13.15 million | Q2 2021: $12.66 million | Q3 2021: $34.28 million | Q1 2022: $14.26 million | Q2 2022: $11.95 million | Q3 2022: $23.19 million | Q1 2023: $13.13 million | Q2 2023: $13.17 million | Q3 2023: $22.06 million | Q1 2024: $14.84 million | Q2 2024: $19.17 million | Q3 2024: $16.09 million | Q1 2025: $6.69 million | Q2 2025: $9.42 million | Q3 2025: $373.0 thousand.
- Over the full 17 years of available data (2011 to 2025), Astrana Health, Inc.'s Net Income Loss has grown by 14,484.2%.
- Historical annual values: Fiscal year 2025: $22.49 million | Fiscal year 2024: $43.15 million | Fiscal year 2023: $60.72 million | Fiscal year 2022: $45.17 million | Fiscal year 2021: $68.92 million | Fiscal year 2020: $37.87 million | Fiscal year 2019: $14.12 million | Fiscal year 2018: $10.84 million | Fiscal year 2017: $25.80 million | Fiscal year 2017: -$8.97 million | Fiscal year 2016: $11.45 million | Fiscal year 2016: -$9.34 million | Fiscal year 2015: -$1.80 million | Fiscal year 2014: -$5.02 million | Fiscal year 2013: -$8.90 million | Fiscal year 2012: -$720.3 thousand | Fiscal year 2011: -$156.3 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: